Denise Braendgaard: Reimagining Health Systems Through Collective Action
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn:
”What role does imagination play when working towards positive change in complex realities?
This was one of the questions that stayed with Célia Rohrer and me after the 25th Swiss Foundations Symposium.
Under the theme AndAction, the discussions moved beyond tools and strategies to something more fundamental: the mindsets, relationships and human dynamics that allow action to happen:
- Moral imagination.
- Resilience.
- Unity.
- Equity.
- Justice.
- Collaboration.
These topics connect with the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation.
Improving access to care requires a deep understanding of local context, co-creation with partners, and the ability to imagine more equitable health systems shaped by trust and long-term commitment.
As always, it was valuable to connect with peers from across the foundation and NGO sector.
Thank you Swiss Foundations for creating space for reflection and action.
The final question of the day felt simple, but urgent: What can we do now? For me, it continues with listening, learning and acting together.
What does action look like in your context?”
Other posts featuring Denise Braendgaard on Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH